The Future of New York Life Sciences →
Partner, Third Rock Ventures
Serial Entrepreneur and Investor
Co-Founder and CEO, Wetpaint
Founder, Gilt Groupe
Managing Partner at Pappas Ventures
Nobel Laureate, Professor of Biology, Caltech
Executive Partner, Sofinnova Ventures
May 21, 2019 · Boston
May 29, 2019 · San Diego
June 13, 2019 · San Francisco
Sigilon Therapeutics uses a capsule it developed to safely deliver engineered cells, which can deliver targeted protein therapeutics. Image courtesy of Sigilon.
Sponsored · Whitepaper
Keep easily accessible, historical records to aid in root cause analysis for deviations
From Our Editors · Special Report
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.